Amiodarone-related pulmonary mass and unique membranous glomerulonephritis in a patient with valvular heart disease: Diagnostic pitfall and new findings

Pathology International

Volumn 58, Issue 10, 2008, Pages 657-663

  Kimura, Tokuhiro ^a   Kuramochi, Shigeru ^a,b   Katayama, Takaharu ^a   Yoshikawa, Tsutomu ^a   Yamada, Taketo ^a   Ueda, Yoshihiko ^c   Okada, Yasunori ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^c DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Amiodarone; Glomerulonephritis; Lung; Positron emission tomography; Proteinuria

Indexed keywords

AMIODARONE; CANDESARTAN HEXETIL; CARVEDILOL; DIGOXIN; DIURETIC AGENT; FLUORODEOXYGLUCOSE F 18; FUROSEMIDE;

AGED; ANAMNESIS; ARTICLE; AUTOPSY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG TUMOR; MALE; MEMBRANOUS GLOMERULONEPHRITIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEINURIA; VALVULAR HEART DISEASE;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; CYTOPLASM; DIAGNOSTIC ERRORS; FATAL OUTCOME; FOAM CELLS; GLOMERULONEPHRITIS, MEMBRANOUS; HEART VALVE DISEASES; HEMOSIDERIN; HUMANS; LUNG; LUNG DISEASES; LUNG NEOPLASMS; LYMPHOCYTES; MALE; PLASMA CELLS; PROTEINURIA;

EID: 51749084888     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2008.02286.x     Document Type: Article

References (22)

1. Wilson JS, Podrid PJ. Side effects from amiodarone. Am Heart J 1991 121 : 158 71.
2. Kennedy JI, Myers JL, Plumb VJ, Fulmer JD. Amiodarone pulmonary toxicity. Clinical, radiologic, and pathologic correlations. Arch Intern Med 1987 147 : 50 55.
3. Myers JL, Kennedy JI, Plumb VJ. Amiodarone lung: Pathologic findings in clinically toxic patients. Hum Pathol 1987 18 : 349 54.
4. Bedrossian CW, Warren CJ, Ohar J, Bhan R. Amiodarone pulmonary toxicity: Cytopathology, ultrastructure, and immunocytochemistry. Ann Diagn Pathol 1997 1 : 47 56.
5. Colgan T, Simon GT, Kay JM, Pugsley SO, Eydt J. Amiodarone pulmonary toxicity. Ultrastruct Pathol 1984 6 : 199 207.
6. Arnon R, Raz I, Chajek-Shaul T, Berkman N, Fields S, Bar-On H. Amiodarone pulmonary toxicity presenting as a solitary lung mass. Chest 1988 93 : 425 7.
7. Piccione W Jr., Rosenberg LP, Faber MS. Amiodarone-induced pulmonary mass. Ann Thorac Surg 1989 47 : 918 19.
8. Azzam I, Tov N, Elias N, Naschitz JE. Amiodarone toxicity presenting as pulmonary mass and peripheral neuropathy: The continuing diagnostic challenge. Postgrad Med J 2006 82 : 73 5.
9. Omeroglu G, Kalugina Y, Ersahin C, Wojcik EM. Amiodarone lung toxicity in a cardiac transplant candidate initially diagnosed by fine-needle aspiration: Cytologic, histologic, and electron microscopic findings. Diagn Cytopathol 2006 34 : 351 4.
10. Jacobs MB. Serum creatinine increase associated with amiodarone therapy. N Y State J Med 1987 87 : 358 9.
11. Pollak PT, Sharma AD, Carruthers SG. Creatinine elevation in patients receiving amiodarone correlates with serum amiodarone concentration. Br J Clin Pharmacol 1993 36 : 125 7.
12. Caubarrere I, Bonan G, Venet A et al. [Pneumopathies caused by hypersensitivity to amiodarone and associated nephropathies. Study by alveolar lavage]. Ann Med Interne (Paris) 1985 136 : 311 15 (In French).
13. Moreau X, Quilichini R, Aubert L, Chagnon A. [Nephrotic syndrome and multivisceral manifestations in a patient treated with amiodarone]. Ann Med Interne (Paris) 1986 137 : 603 4 (In French).
14. Kuhlman JE, Teigen C, Ren H, Hruban RH, Hutchins GM, Fishman EK. Amiodarone pulmonary toxicity: CT findings in symptomatic patients. Radiology 1990 177 : 121 5.
15. Ren H, Kuhlman JE, Hruban RH, Fishman EK, Wheeler PS, Hutchins GM. CT-pathology correlation of amiodarone lung. J Comput Assist Tomogr 1990 14 : 760 65.
16. Reasor MJ, Kacew S. An evaluation of possible mechanisms underlying amiodarone-induced pulmonary toxicity. Proc Soc Exp Biol Med 1996 212 : 297 304.
17. Himmel HM, Dobrev D, Grossmann M, Ravens U. N-desethylamiodarone modulates intracellular calcium concentration in endothelial cells. Naunyn Schmiedebergs Arch Pharmacol 2000 362 : 489 96.
18. Demura Y, Tsuchida T, Ishizaki T et al. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med 2003 44 : 540 48.
19. Deichen JT, Prante O, Gack M, Schmiedehausen K, Kuwert T. Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro. Eur J Nucl Med Mol Imaging 2003 30 : 267 73.
20. Schwartz MM. Membranous glomerulonephritis. In : Jennette JC, Olson JL, Schwartz MM, Silva FG, eds. Heptinstall's Pathology of the Kidney, 6th edn. Philadelphia, PA : Lippincott Williams & Wilkins, 2007 205 52.
21. Hoorntje SJ, Kallenberg CG, Weening JJ, Donker AJ, The TH, Hoedemaeker PJ. Immune-complex glomerulopathy in patients treated with captopril. Lancet 1980 1 : 1212 15.
22. Pichler WJ, Schindler L, Staubli M, Stadler BM, de Weck AL. Anti-amiodarone antibodies: Detection and relationship to the development of side effects. Am J Med 1988 85 : 197 202.